Targeting the host ER alpha glucosidases I and II as antiviral therapy

Targeting the host ER alpha glucosidases I and II as antiviral therapy

Bibliographic Details
Main Authors:	Branza-Nichita, N, Lazar, C, Macovei, A, Durantel, D, Dwek, R, Zitzmann, N
Format:	Conference item
Published:	Wiley 2007

Similar Items

Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
by: Lazar, C, et al.
Published: (2007)

The bovine viral diarrhoea virus: a model for the study of antiviral molecules interfering with N-glycosylation and folding of envelope glycoprotein
by: Durantel, D, et al.
Published: (2015)

Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
by: Durantel, D, et al.
Published: (2001)

Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers.
by: Branza-Nichita, N, et al.
Published: (2001)

Role of disulfide bond formation in the folding and assembly of the envelope glycoproteins of a pestivirus.
by: Branza-Nichita, N, et al.
Published: (2002)

Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus.
by: Durantel, D, et al.
Published: (2004)

Brefeldin A inhibits pestivirus release from infected cells, without affecting its assembly and infectivity.
by: Macovei, A, et al.
Published: (2006)

Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles.
by: Chapel, C, et al.
Published: (2006)

Structural insights into the broad-spectrum antiviral target endoplasmic reticulum alpha-glucosidase II
by: Zitzmann, N, et al.
Published: (2018)

Cholesterol depletion of hepatoma cells impairs hepatitis B virus envelopment by altering the topology of the large envelope protein
by: Dorobantu, C, et al.
Published: (2011)

Structural and functional studies of the antiviral target proteins HCV p7 and ER alpha-glucosidase II
by: Hensen, M
Published: (2019)

The pestivirus E(rns) glycoprotein interacts with E2 in both infected cells and mature virions.
by: Lazar, C, et al.
Published: (2003)

Role of N-glycan trimming in the folding and secretion of the pestivirus protein E(rns)
by: Branza-Nichita, N, et al.
Published: (2004)

Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells.
by: Macovei, A, et al.
Published: (2010)

Long alkylchain iminosugars block the HCV p7 ion channel
by: Pavlovic, D, et al.
Published: (2005)

Host-targeting oral antiviral drugs to prevent pandemics
by: Dwek, RA, et al.
Published: (2022)

Alpha-glucosidase inhibitors prevent the assembly and induce a reduction of HCV infectivity
by: Chapel, C, et al.
Published: (2006)

Alpha-glucosidase inhibitors as potential broad based anti-viral agents
by: Mehta, A, et al.
Published: (1998)

Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals
by: Caputo, A, et al.
Published: (2016)

Inhibitors of alpha glucosidases impair HCV pseudoparticles morphogenesis, prevent viral secretion and entry into hepatoma cells
by: Chapel, C, et al.
Published: (2005)

Alpha-glucosidases inhibitors impair HCV pseudoparticles morphogenesis, prevent viral secretion and entry into hepatoma cells
by: Chapel, C, et al.
Published: (2005)

Inhibitors of alpha glucosidases impair HCV pseudoparticles morphogenesis, prevent viral secretion and entry into hepatoma cells
by: Chapel, C, et al.
Published: (2005)

Iminosugars inhibit dengue virus production via inhibition of ER alpha-glucosidases – not glycolipid processing enzymes
by: Sayce, AC, et al.
Published: (2016)

Virus morphogenesis and viral entry as alternative targets for novel hepatitis C antivirals
by: Chapel, C, et al.
Published: (2006)

Activation of ERAD pathway by human hepatitis B virus modulates viral and subviral particle production.
by: Catalin Lazar, et al.
Published: (2012-01-01)

Liposome treatment of viral infections
by: Dwek, R, et al.
Published: (2011)

Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells.
by: Pollock, S, et al.
Published: (2010)

Targeting a host process as an antiviral approach against dengue virus
by: Sayce, A, et al.
Published: (2010)

Targeting ER α-glucosidase I with a single-dose iminosugar treatment protects against lethal influenza and dengue virus infections
by: Warfield, K, et al.
Published: (2020)

Iminosugars in combination with interferon and ribavirin permanently eradicate noncytopathic bovine viral diarrhea virus from persistently infected cells.
by: Woodhouse, S, et al.
Published: (2008)

N-substituted valiolamine derivatives as potent inhibitors of endoplasmic reticulum α-glucosidases I and II with antiviral activity
by: Karade, S, et al.
Published: (2021)

Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.
by: Chapel, C, et al.
Published: (2007)

Structural studies of Endoplasmic Reticulum Glucosidase II
by: Caputo, A, et al.
Published: (2015)

Glycobiology against viruses: Antiviral drug discovery
by: Zitzmann, N, et al.
Published: (2006)

Iminosugar antivirals: the therapeutic sweet spot
by: Alonzi, D, et al.
Published: (2017)

Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles
by: Chapel, C, et al.
Published: (2006)

Long chain N-alkyl compounds and Oxa-derivatives thereof and use antiviral compositions
by: Zitzmann, N, et al.
Published: (2001)

Glucosylated free oligosaccharides are biomarkers of endoplasmic- reticulum alpha-glucosidase inhibition.
by: Alonzi, D, et al.
Published: (2008)

Antiviral effects of an iminosugar derivative on flavivirus infections.
by: Wu, S, et al.
Published: (2002)

Improved cellular inhibitors for glycoprotein processing alpha-glucosidases: biological characterisation of alkyl- and arylalkyl-N-substituted deoxynojirimycins
by: Alonzi, D, et al.
Published: (2009)